(2026). Biomarker‐based long‐term safety and efficacy of PD‐1/PD‐L1 inhibitors combined with chemotherapy in advanced gastroesophageal carcinomas: A systematic review and meta‐analysis. Precision Medical Sciences.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Biomarker‐based Long‐term Safety and Efficacy of PD‐1/PD‐L1 Inhibitors Combined with Chemotherapy in Advanced Gastroesophageal Carcinomas: A Systematic Review and Meta‐analysis."
Precision Medical Sciences 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Biomarker‐based Long‐term Safety and Efficacy of PD‐1/PD‐L1 Inhibitors Combined with Chemotherapy in Advanced Gastroesophageal Carcinomas: A Systematic Review and Meta‐analysis."
Precision Medical Sciences, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.